Published in Cesk Dermatol on June 01, 1973
The sequences of 5-methylcytosine in the DNA of Escherichia coli. Biochem Biophys Res Commun (1965) 1.19
Increased transformation frequency in E. coli. Biochem Biophys Res Commun (1978) 1.13
Incorporation of 5-azacytidine into nucleic acids of Escherichia coli. Biochim Biophys Acta (1968) 1.05
The effect of nucleosides on the phosphorolysis of thymidine by normal and phage-infected cells of E. coli. Biochem Biophys Res Commun (1968) 1.03
The action of 5-azacytidine on bacteria infected with bacteriophage T4. Biochim Biophys Acta (1967) 1.02
Ringworm infection among agricultural workers. Int J Epidemiol (1976) 0.96
An electron microscopic heteroduplex study of the sequence relations between the bacteriophages LP52 and theta. Mol Gen Genet (1985) 0.94
Plurimodal distribution of base composition in DNA of some higher plants. Biochim Biophys Acta (1974) 0.92
The effects of 5-azacytidine and 5-azauridine on protein synthesis in Escherichia coli. Biochem Biophys Res Commun (1970) 0.90
Inducible nucleoside permease in Escherichia coli. Biochem Biophys Res Commun (1974) 0.90
The components of the nucleoside-transporting system in Escherichia coli. Biochim Biophys Acta (1972) 0.89
Inhibition of nucleoside-binding sites by nucleoside analogues in Escherichia coli. Nucleic Acids Res (1974) 0.87
Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha. Acta Virol (1989) 0.86
Inhibition of protein synthesis by 5-azacytidine in Escherichia coli. Biochim Biophys Acta (1967) 0.86
An interferon like substance induced by mannans. Acta Virol (1967) 0.85
Sequence homology and recombination between the genomes of morphologically dissimilar bacteriophages LP 52 and theta. Mol Gen Genet (1982) 0.85
A comparative study of G+C-rich satellite components of sheep and goat DNA. Nucleic Acids Res (1979) 0.84
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol (1998) 0.83
Double-stranded f 2 phage RNA as interferon inducer. Acta Virol (1971) 0.82
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
The mode of action of 5-aza-2'-deoxycytidine in Escherichia coli. Eur J Biochem (1970) 0.81
Release of interferon by mouse peritoneal cells in vitro. The requirement of contact with endotoxin and the temperature dependence of release. Acta Virol (1969) 0.81
Enhancing effect of anti-endotoxic serum on interferon induction in mouse peritoneal cells by endotoxin. Acta Virol (1968) 0.81
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha. Immunology (1991) 0.81
Electrophoretic profiles and activities of human interferon in heterologous cells. Intervirology (1974) 0.81
Dependence of antiviral activity on molecular weight in an interferon stimulator of the natural double-stranded RNA type. Acta Virol (1973) 0.81
Relationship between antifungal activity and hydrophobicity of kojic acid derivatives. Folia Microbiol (Praha) (1993) 0.80
Activation of NK cells in subjects exposed to mild hyper- or hypothermic load. J Interferon Res (1988) 0.79
Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.78
The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol (1967) 0.78
Interferon as therapeutic agent. Acta Virol (1983) 0.78
Complex formation of daunomycin with double-stranded RNA. FEBS Lett (1973) 0.78
The reticuloendothelial system and virus infection. II. Production of interferon- and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch Gesamte Virusforsch (1965) 0.78
Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon. Acta Virol (1986) 0.78
Activation of the complement system by interferon inducers. Acta Virol (1972) 0.78
A compact form of double-stranded RNA in solutions containing poly(ethyleneglycol). Nucleic Acids Res (1976) 0.77
Current view on the perspectives of interferon therapy. Acta Virol (1986) 0.77
Are the acid-labile interferon alpha and interferon omega-1 identical? Virology (1991) 0.77
The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma (1977) 0.77
Therapeutic use of double-stranded RNAs in man. Tex Rep Biol Med (1983) 0.77
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies. Acta Virol (1976) 0.77
Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol (1972) 0.77
Action of dimeric hybrids of native and selectively alkylated ribonuclease A on double-stranded ribonucleic acid. Biochem J (1974) 0.77
The effect of nickel sulphate, potassium dichromate, cobalt nitrate and cadmium sulphate on the proteins of cellular contacts and actin skeleton of cultivated human keratinocytes. Bratisl Lek Listy (2002) 0.76
Different types of precipitating antibodies in early and late porcine anti-dinitrophenyl sera. Immunochemistry (1974) 0.76
[Borrelia burgdorferi antibodies in scleroderma circumscripta, lichen sclerosus et atrophicus, erythema nodosum, granuloma annulare, erythema annulare and chronic urticaria]. Bratisl Lek Listy (2000) 0.76
Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Mol Immunol (1992) 0.76
[N[2-hydroxyethyl] palmitamide repeated administration effect on interferon production in mouse organism after phage double-stranded ribonucleic acid [ds-RNA] application (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1978) 0.76
First proof about the occurrence of Ctenomyces serratus Eidam in soil samples in Czechoslovakia. Mycopathol Mycol Appl (1967) 0.76
Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Acta Virol (1989) 0.76
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Immunol Lett (1993) 0.76
Effect of impulsin treatment of interferon production and antiviral resistance of mice. Arch Immunol Ther Exp (Warsz) (1977) 0.76
Ecology and transmission of Microsporum gypseum from soil to man. Sabouraudia (1970) 0.76
Basic polypeptides as histone models. Effect of conformation, base composition and methylation of nucleic acids on the interaction with H1 and histone models and on the circular dichroism of complexes. Nucleic Acids Res (1976) 0.75
Interactions between viral infection and immune mechanisms. Comp Immunol Microbiol Infect Dis (1980) 0.75
Inducible and constitutive nucleoside-binding sites in Escherichia coli: differential inhibition by nucleoside analogues. Nucleic Acids Res (1974) 0.75
[Microsporum canis infection in rabbits and its transmission to humans]. Mycoses (1989) 0.75
Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med (1977) 0.75
The metabolism of isocytidine in Escherichia coli. Nucleic Acids Res (1974) 0.75
[Peritoneal macrophages and interferon formation (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1974) 0.75
Decrease of sensitivity to cell-growth inhibitory effect of interferon in human embryo cells after infection with SV40. Acta Virol (1979) 0.75
Contribution to the problem of purity of interferon preparations. Acta Virol (1973) 0.75
Some properties of interferon released by mouse peritoneal leukocytes stimulated with endotoxin, mannan and Newcastle disease virus in vitro. Acta Virol (1970) 0.75
Some biological activities of rabbit anti-interferon serum. Acta Virol (1976) 0.75
Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice. Acta Virol (1980) 0.75
Evaluation of the Czechoslovak double-stranded RNA preparation as inducer of interferon in model experiments. Acta Virol (1972) 0.75
Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons. Acta Virol (1990) 0.75
The effect of interferon induction on complement level in rat. Acta Biol Med Ger (1979) 0.75
Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells. Acta Biol Med Ger (1979) 0.75
Production of human leukocyte interferon for clinical use under immunoelectrophoretic control. Acta Biol Med Ger (1979) 0.75
Relation of incubation temperature to interferon production in mouse peritoneal cells infected with Newcastle disease virus. Acta Virol (1969) 0.75
The effect of native and sonicated double-stranded polyribonucleotides on the course of spontaneous autoimmune disease in NZB and NZB/Swiss F1 mice. Acta Virol (1979) 0.75
Antiviral and anticellular effects of interferon on the mouse embryonic cells transformed by viruses and/or chemical carcinogen. Acta Biol Med Ger (1979) 0.75
Effect of different polyribonucleotides on the induction of antibodies to DNA and RNA and serum complement level in mice. Acta Biol Med Ger (1979) 0.75
[Double stranded RNA and a nonspecific stimulator of the organism's defense mechanism]. Bratisl Lek Listy (1978) 0.75
Some biological activites of rabbit anti-interferon serum. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Antigenic link between human interferons-alpha and -beta: the common epitope 1. J Interferon Res (1990) 0.75
Long-term culture of guinea pig tongue cells: a suitable interferon system. Acta Virol (1979) 0.75
[A hyperthermic bath increases the cytolytic activity of NK cells]. Cas Lek Cesk (1987) 0.75
Production of interferon and other lymphokines during murine tumour growth. I. Lymphokines in cell--free fluid of rat Zajdela ascites hepatoma. Acta Virol (1980) 0.75
Patterns of interferon induction in leuckocytes. Acta Microbiol Pol A (1973) 0.75
Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma. Acta Virol (1988) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
Purification of mouse interferon on specifically purified immunoadsorbent. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Levels of complement during interferon induction. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Preparation of highly sensitive mouse hybrid cells for interferon assays. J Immunol Methods (1989) 0.75
Release of an interferon-like virus inhibitor during contact of mouse leukocytes with target cells. Acta Virol (1970) 0.75
Antiviral and cell-growth inhibitory effect of interferon. Biomedicine (1973) 0.75
Quantitative immunoelectrophoresis of human interferon. A new approach to characterization of interferon preparations. Acta Virol (1978) 0.75
Interferon research and our possibilities. Some concluding thoughts. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels. Acta Virol (1975) 0.75
Murine monoclonal antibodies against human fibroblast (beta) interferon. Correlation of the neutralization of antiviral and antiproliferative activities. Acta Virol (1989) 0.75
Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness. Acta Virol (1988) 0.75
Twenty years after discovery of interferon: the progress and the persistent problems. Acta Biol Med Ger (1979) 0.75
Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35. J Interferon Res (1991) 0.75
Partial heterologous tolerance to interferon production in mice infected with B. pertussis. Acta Virol (1966) 0.75